Uncategorised - European Medical Journal

Diagnostic Approaches for Metastatic Breast Cancer

Bone is the most common site of metastasis in metastatic breast cancer (MBC), yet no standardised imaging method accurately assesses…

Immunotherapy Sequencing in Relapsed/Refractory Multiple Myeloma

Most patients with multiple myeloma undergo several cycles of remission and relapse during their disease journey, and multiple lines of…

AI in Medical Imaging

AI has rapidly emerged as a transformative force in various fields, including healthcare. In the realm of medical imaging, AI-powered…

Review of the European Congress of Radiology (ECR) 2025

A SPECTACLE as always, this year’s European Congress of Radiology (ECR) in Vienna, Austria, opened with a wealth of entrancing…

Sustainability and Equity: AI in Radiology

This years’s European Congress of Radiology (ECR) saw experts in the field flock to Vienna, Austria, for insights and updates presented in…

Early Health Technology Assessment to Detect Incidental Pulmonary Embolisms on CT

Incidental pulmonary embolisms (IPE) on CT are missed in up to 70% of cases. While AI tools for IPE detection exist, an evaluation on if…

Patients’ Perception of Radiographers’ Communication Skills During Planar X-Ray Imaging

To explore patients’ perception of radiographers’ communication skills during planar X-ray imaging examinations at a general hospital…

Novel Therapies Require Novel Imaging

With an impressive attendance of 20,522 participants from 131 countries, the European Congress of Radiology (ECR) 2025 was an epicentre…

Diagnostic Performance of Neural Network Algorithms in Skull Fracture Detection on CT Scans

Radiologists who evaluate CT scans have diagnostic challenges due to the complexity of underlying anatomy and the potential intricacy of…

TRAILBLAZER-ALZ Trial Data Reveals Donanemab Effects in Early Alzheimer's: AAN 2025

At the 2025 American Academy of Neurology (AAN) Annual Meeting in San Diego, new data from the TRAILBLAZER-ALZ clinical trial program highlighted critical risk factors and management strategies for amyloid-related imaging abnormalities (ARIA) in patients with early symptomatic Alzheimer’s disease treated with donanemab.